Utrogestan

Utrogestan

progesterone

Manufacturer:

Lapi
Concise Prescribing Info
Contents
Micronised progesterone
Indications/Uses
Progesterone-deficiency related disorders. Oral: Menstrual irregularity due to dysovulation. Vag: In vitro fertilization (IVF) cycles; alternative to oral route if not tolerable.
Dosage/Direction for Use
Not >200 mg/intake. Progesterone insufficiencies 200-300 mg daily in 1 or 2 divided doses. May increase dose to 600 mg/day in 3 divided doses, in case of aiding pregnancy. Vag Insert 1 cap deeply in the vag. Duration of treatment may depend on indication & efficacy of treatment.
Administration
Should be taken on an empty stomach: Preferably taken at bedtime. Swallow whole w/ a glass of water.
Contraindications
Hypersensitivity. Allergy to peanuts, severe hepatic dysfunction, undiagnosed vag bleeding, mammary or genital tract carcinoma, thrombophlebitis, thromboembolic, disorder, cerebral hemorrhage, porphyria.
Special Precautions
Post-menopausal women; conditions that might aggravate fluid retention eg, HTN, cardiac & renal disease, epilepsy, migraine, asthma; history of depression, diabetes, mild to moderate hepatic dysfunction, migraine or photosensitivity. May affect ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Acne, urticaria, rashes, fluid retention,wt changes, GI & disturbances, breast discomfort, premenstrual syndrome, chloasma, depression, pyrexia, insomnia, alopecia, hirsutism; VTE. Oral: Altered menstrual cycles, amenorrhea, intermenstrual bleeding, headaches. Vag: Local irritation.
Drug Interactions
Bromcriptine, cyclosporine, rifamycin.
ATC Classification
G03DA04 - progesterone ; Belongs to the class of pregnen (4) derivative progestogens.
Presentation/Packing
Form
Utrogestan cap 100 mg
Packing/Price
30's
Form
Utrogestan cap 200 mg
Packing/Price
15's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in